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In utero electroporation is widely used to study neuronal development and function by intro-
ducing plasmid DNA into neural progenitors during embryogenesis. This is an effective and
convenient method of introducing plasmid DNA into neural precursors and is suitable for
manipulating gene expression in cells of the CNS. However, the applicability of this technique
is comparatively limited to neuronal research, as the plasmid DNA introduced into neural pro-
genitors during embryogenesis is diluted by cell proliferation and is not stably maintained in
glial cells generated around and after birth. To overcome this limitation, we applied the Tol2
transposon system, which integrates a transgene into the genome of the host cell, to in utero
electroporation. With this system, we conﬁrmed that the transgene was effectively maintained
in the progeny of embryonic neural precursors, astrocytes and oligodendrocytes. Using the
glial promoters GFAP and S100b, targeted and stable expressions of transgenes in glia were
obtained, which enabled the expression of different transgenes simultaneously in neurons and
glia. Glia-targeted expression of the transgene that causes neuronal migration defect was
achieved without the defect. Thus, use of the Tol2 transposon system in combination with
in utero electroporation is a powerful method for studying glia-neuron interactions in vivo.
Introduction
Evidence accumulated over the last decade has shown
that glial cells not only support neuronal survival but
also contribute signiﬁcantly to the formation, operation
and adaptation of neural networks (Wang & Bordey
2008). Although glia are often studied in vitro, in vivo
investigations are required to elucidate their physiolog-
ical roles. Currently, viral transduction and transgenic
approaches are used to manipulate gene expression in
glial cells in vivo (Levison & Goldman 1993; Burns
et al. 2009). However, the surgery required to intro-
duce genes of interest at postnatal stages causes local tis-
sue damage and induces immune responses by
microglia and astrocytes, which complicates the study
of transgenes under normal, noninﬂammatory condi-
tions. Although transgenic approaches are powerful
and reliable strategies to study gene function, the ﬁnan-
cial costs limit their use. Thus, a more convenient and
less invasive methodology is needed to accelerate the
study of glial function by manipulating gene expression
in vivo.
In utero electroporation is widely used to introduce
transgenes into neural precursors to study neuronal
development and function (Fukuchi-Shimogori &
Grove 2001; Saito & Nakatsuji 2001; Tabata & Nakaj-
ima 2001). Compared with surgical viral transfer
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501carried out at the postnatal stage, it is a convenient and
less invasive method, similar to in ovo electroporation
(Muramatsu et al. 1997; Funahashi et al. 1999). Typi-
cally, the in utero electroporation method involves
injecting a conventional expression plasmid vector into
the ventricles of the embryonic brain and using electri-
cal pulses to transfer the DNA into the VZ (ventricular
zone)⁄SVZ (subventricular zone) cells adjacent to the
ventricles. The optimal developmental stage for using
this method in mice is from about embryonic day (E)
10.5–16.5. Although this method is effective for study-
ing neurons, as the plasmid is diluted at each division,
it is not suitable to maintain the transgene in highly
proliferative neural precursors and their descendants,
glial cells (Miller & Gauthier 2007).
The Tol2 transposon, from the medaka Oryzias lati-
pes, has been used to integrate transgenes into the
genomes of ﬁsh, amphibians, chicken and ﬂies, as well
as into mammalian cells in culture (Kawakami et al.
2000; Kawakami & Noda 2004; Hamlet et al. 2006;
Tanabe et al. 2006; Sato et al. 2007; Watanabe et al.
2007; Urasaki et al. 2008). In the Tol2 transposon–
mediated gene transfer system (hereafter, the Tol2 sys-
tem), the Tol2 transposase (T2TP) mediates integration
of a transgene cassette ﬂanked by Tol2 cis-sequences
into the host genome. We reported using the Tol2 sys-
tem with the in ovo electroporation of chicken
embryos, and achieving stable expression of the trans-
gene in proliferative cells (Sato et al. 2007). These ﬁnd-
ings prompted us to combine the Tol2 system with
in utero electroporation to alter gene expression in glial
cells in the mouse brain. We report here that our com-
bination of transposon-mediated gene transfer system
with in utero electroporation enables the expression of a
transgene stably and efﬁciently in (i) mitotic neural pre-
cursor cells (radial glia) during development and (ii)
macroglia, including both cortical astrocytes and oligo-
dendrocytes, after birth. Moreover, this method
allowed the labeling of neurons and glia with different
markers and⁄or alteration of gene expression differen-
tially and simultaneously in these cell types, using cell-
type-speciﬁc promoters to drive different transgenes.
Results
Expression of a Tol2-ﬂanked gene was maintained
when introduced with theTol2 transposase
Expression in neural precursor cells (radial glia)
We ﬁrst investigated whether a transgene cloned into
the Tol2 vector was efﬁciently maintained in the prog-
eny of electroporated neural progenitor cells during
brain development. For this purpose, we introduced an
expression cassette plasmid containing CAGGS-EGFP
ﬂanked by the Tol2 cis-sequences (pT2K-CAGGS-
EGFP) with or without the plasmid for the Tol2 trans-
posase (pCAGGS-T2TP) into the mouse brain at E11.5
or E12.5 by in utero electroporation and examined
EGFP expression in the brain at E16.5. pCAGGS-
DsRed1, the plasmid containing CAGGS-DsRed1
without the Tol2 cis-sequences, was introduced along
with the other plasmid(s) as a marker of electroporation
efﬁciency (Fig. 1A). When pCAGGS-T2TP was not
included, cells expressing EGFP and DsRed1 were both
observed almost only in the cortical plate (Fig. 1B). In
contrast, when pCAGGS-T2TP was included, broader
EGFP expression was detected: it was expressed in the
cortical plate (CP), intermediate zone (IZ), SVZ and
VZ (Fig. 1C). Some of the EGFP-positive cells in the
VZ had elongated radial glia-like processes extending to
the edge of the ventricular zone (Fig. 1D, arrows) and
were positive for the neural precursor marker, nestin
(Fig. 1E). In addition, some of these precursors were
located in the apical side, where mitosis occurs, and
were positive for the mitosis marker, phospho-Histone
H3 (PH3) (Fig. 1F). The intensity of EGFP ﬂuores-
cence in the T2TP-transduced VZ⁄SVZ was much
higher than that in the same regions without T2TP
Figure 1 Persistent expression of Tol2-ﬂanked EGFP in proliferative cells during neural development. (A) Schematic representa-
tion of plasmids introduced into the dorsolateral telencephalon of mouse embryos. (B–D) Coronal vibratome sections showing
cerebral cortex electroporated at E11.5 and ﬁxed at E16.5. (B) Without transposase. (C,D) With transposase. High-magniﬁcation
view of VZ is shown in (D). Radial glia-like processes are indicated by arrows. (E,F) Expressions of EGFP introduced at E12.5
were observed after 4 days (E16.5) and some were positive for radial glial marker (nestin, E) or mitosis marker (PH3, F). Views
from XY, XZ and YZ are shown in the right lower panels. (G) Relationship between the relative efﬁciency of electroporation
and the retention of Tol2-ﬂanked EGFP with or without T2TP. The relative efﬁciency of electroporation is represented as the
relative intensity of DsRed1 in CP, and the retention of Tol2-ﬂanked EGFP was assessed by evaluating the relative intensity of
EGFP in the SVZ⁄VZ. (H,I) Retention of Tol2-ﬂanked EGFP in late-born neurons. (H–H¢¢) Coronal cryosection of the cerebral
cortex electroporated at E12.5 with T2TP and ﬁxed at P8. The pial surface is indicated by the white dotted line. (I) The numbers
of neurons expressing Tol2-ﬂanked EGFP and⁄or TagRFP. Nucleus was counterstained with HOECHST 33342 (B–D,H). Scale
bars, 250 lm in (B,C,H,H¢) and 25 lm in (D–F).
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503introduction,regardlessoftheelectroporationefﬁciency
(Fig. 1G). The effect of T2TP was not dependent on
which ﬂuorescent proteins were ﬂanked by the Tol2 cis-
sequences (data not shown).
Next, we examined whether the Tol2-ﬂanked trans-
gene was inherited by the descendants of the electropo-
rated radial glia. We carried out in utero electroporation
with pT2K-CAGGS-EGFP, pCAGGS-T2TP and the
control plasmid, pCAX2-TagRFP, at E12.5 and ana-
lyzed the distribution of neurons expressing EGFP and
TagRFP on postnatal day (P) 8, when radial neuronal
migration is mostly ﬁnished. We anticipated that EGFP
expression would overlap with TagRFP expression in
the inner cortical layers but would extend farther than
TagRFP in the outer layers, because neurons of the
outer cerebral cortical layers are born later than those
in the inner layers (Takahashi et al. 1999). Indeed, neu-
rons expressing EGFP were found from layer VI to
upper layer II⁄III, whereas those expressing TagRFP
were conﬁned mainly to layers VI to IV (Fig. 1H,I).
These results suggested that the Tol2 transposase stably
integrated the Tol2-ﬂanked transgene into the genome
of proliferative neural progenitors.
Expression in perinatally generated glial cells
As neural progenitor cells switch from generating
neurons to generating glia around the time of birth, we
next examined whether glial cells could inherit the
transgene introduced into the electroporated neural
progenitor cells using our system. pT2K-CAGGS-
EGFP was introduced into the cortex by in utero elec-
troporation at E14.5 with or without pCAGGS-T2TP,
and the expression of EGFP was examined at the stages
when glial morphological differentiation was evident
(P16–17). As shown earlier, when T2TP was not
expressed, EGFP was found only in pyramidal neurons
located mainly in layers II–IV, which are born just after
E14.5 (Fig. 2A, left panel) (Langevin et al. 2007).
When T2TP was co-introduced with pT2K-CAGGS-
EGFP, EGFP was expressed not only in the pyramidal
neurons of the cortical plate, but also in cells showing
morphologies and distributions distinct from those of
neurons (Fig. 2A, right panel, and B,C). These non-
neuronal EGFP-positive cells were observed from the
SVZ to the marginal zone of the cortex (Fig. 2A right,
arrows). The majority exhibited features characteristic
of two types of astrocyte: ﬁbrous astrocytes, which are
located mainly in layer I and white matter and have a
root-like morphology (Fig. 2B), and protoplasmic
astrocytes, which are distributed throughout the cortex
and have a bushy shape (Fig. 2C) (Kimelberg 2004).
(A)
(B) (C)
(D1) (D2) (E1) (E2)
(E4) (E3) (D4) (D3)
(F1) (F2) (G1) (G2)
(G4) (G3) (F4) (F3)
Figure 2 Tol2-ﬂanked transgene was inherited by glial cells
generated postnatally. (A) Emergence of non-neuronal cells
labeled by Tol2-ﬂanked EGFP (right, arrows). The dorsal telen-
cephalon was electroporated to introduce pT2K-CAGGS-EGFP
at E14.5 without (left) or with (right) pCAGGS-T2TP. The
brain was analyzed at P16–17. (B,C) Higher magniﬁcation of
EGFP-positive cells with non-neuronal morphology showing
ﬁbrous astrocytes in the marginal zone (B) and protoplasmic as-
trocytes in the cortical plate (C). (D–G) Immunostaining of vi-
bratome sections against cell-type-speciﬁc markers. Higher
magniﬁcation view of the insets in 1 is shown in 2–4. EGFP-
expressing cells were positive for GFAP (D), S100 (E), or Olig2
(G) and negative for the neuronal marker, NeuN (F). Merged
image of EGFP and cell type markers is shown in 2. Scale bars,
250 lm (A,D1,E1,F1,G1) and 25 lm (B,C,D2–4,E2–4, F2–
4,G2–4). The pial surface is indicated by the white dotted line.
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504We also conﬁrmed the astrocytic properties of
these EGFP-positive cells by immunohistochemical
staining for GFAP (Fig. 2D) and for S100 (Fig. 2E).
Neither of these cell types showed labeling with an
antibody against NeuN, a neuronal marker (Fig. 2F).
Some of the non-neuronal EGFP-positive cells were
also positive for Olig2 (Fig. 2G), indicating that the
stable integration of the transgene into neural progen-
itors also led to transgene expression in both astrocyte
and oligodendrocyte lineages (Levison & Goldman
1993; Ono et al. 2008).
EGFP expression in glial cells was almost com-
pletely dependent on T2TP co-electroporation
(Fig. 3A). To verify that the electroporated cells were
proliferative postnatally, we carried out BrdU labeling
at the stage when vigorous gliogenesis occurs (P4)
and observed the mitosis of EGFP-positive cells
(Fig. 3B). Thus, combining in utero electroporation
with the Tol2 system enabled the expression of a
transgene in glial cells born after neurogenesis was
completed (Fig. 3C).
Glia-targeted gene expression using cell-type-
speciﬁc promoters
Although our method allowed the expression of vari-
ous transgenes in late-born glia using the broadly
active CAG promoter with the Tol2 system, the per-
sistent and strong expression of a transgene from the
neurogenic stages to postnatal life may affect neuronal
development, in turn leading to aberrant glial devel-
opment. To dissect the molecular mechanisms that
underlie the development and physiological function
of glial cells, glia-targeted manipulation of various
genes is required. Therefore, we used two cell-type-
speciﬁc promoters, i.e. those for mouse GFAP (Miura
et al. 1990) and S100b (Vives et al. 2003), which are
expressed primarily in glial cells, mainly in astrocytes.
In utero electroporation of a plasmid encoding
Tol2-ﬂanked EGFP driven by the mouse GFAP pro-
moter (pT2K-GFAP-EGFP) and pCAGGS-T2TP at
E14.5 into lateral VZ of the neocortex resulted in
EGFP expression restricted to astrocytes at the stages
when astrocytes are distributed throughout the cortex
(P10–12) (Fig. 4A). In these experiments, neurons
(A)
(B)
(C)
Figure 3 The Tol2 system resulted in postnatal expression of
the transgene by mitotic cells. (A) Relationship between the
relative efﬁciency of electroporation and the number of labeled
glial cells at P16–17. (B) Retention of the transgene by mitotic
cells at P5 after in utero electroporation at E14.5. Some EGFP-
positive cells (green) were also positive for BrdU (magenta). A
higher magniﬁcation view of the inset is shown. Scale bars,
50 lm (left panel) and 10 lm (right three panels). The pial
surface is indicated by the white dotted line. (C) Schematic
image of the Tol2 transposon system combined with the in ute-
ro electroporation method. (1) Without transposase, the plas-
mid introduced into progenitor cells was diluted following cell
proliferation, and the expression of the transgene was restricted
to cells born and becoming postmitotic soon after electropora-
tion. (2) With the Tol2 transposase, a transgene ﬂanked by the
Tol2 cis-sequences was integrated into the genomic DNA of
progenitor cells and inherited by its descendants, including
neurons and glia.
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505were labeled with TagRFP, encoded by the pCAX2-
TagRFP plasmid, which was co-introduced during
electroporation and was not ﬂanked by the Tol2
cis-sequences. Almost all of the EGFP-positive cells
(92%) also expressed the endogenous GFAP protein
(Fig. 4B). Similarly, co-electroporation of the S100b
promoter-driven EGFP (pT2K-S100b-EGFP) with
pCAGGS-T2TP at E14.5 caused EGFP expression in
astrocytes distributed throughout the cortex at P10–
12 (Fig. 4C). Approximately 84% of the EGFP-posi-
tive cells showed colocalized immunoreactivity for
the S100 protein (Fig. 4D). In both experiments, the
expression patterns of EGFP were evaluated by
counting cell numbers in each layer (layer I–VI,
white matter: WM, and SVZ). Cells expressing
pT2K-GFAP-EGFP tended to localize in layer I,
WM and SVZ, whereas those expressing pT2K-
S100b-EGFP were distributed throughout the cortex
(Fig. 4E). Taken together, our data show that glial-
targeted expression of an exogenous gene using cell-
type-speciﬁc promoters was achieved. In addition,
immunostaining against GFP visualized cells exhibit-
ing morphology typical of oligodendrocytes, suggest-
ing that the Tol2 transposase enables introduction of
transgenes into both astrocyte and oligodendrocyte
lineages by in utero electroporation (Fig. 4F and see
also Fig. 2G) (Zerlin et al. 2004). Furthermore, these
experiments demonstrated that two different transg-
enes could be expressed in astrocytes and adjacent
neurons simultaneously and independently (Fig. 4G).
We next examined whether these glia-targeted
promoters with the Tol2 system could be used to
express a transgene without affecting neuronal devel-
opment. As it is known that radial glial cells begin to
express GFAP at later stages of neurogenesis, we
examined the expression of pT2K-GFAP- or pT2K-
S100b-EGFP at E18.5, 4 days after electroporation.
Both pT2K-GFAP-EGFP and pT2K-S100b-EGFP
expressions were detected in nestin-positive radial glia
by immunostaining with anti-GFP antibody
(Fig. 5A,B), although the level of EGFP expression
was too low for visualization without staining (data
not shown). Previous studies showed that transient
expression of dominant negative or constitutively
active form of Rac1 (Rac1CA) under the CAG
promoter disturbed the radial migration of neurons
(Kawauchi et al. 2003; Konno et al. 2005). We con-
ﬁrmed that when we used our system to express
Rac1CA under the control of the CAG promoter,
only a few neurons expressing the exogenous gene
were present in the cortical plate even at P16, 1 week
after completion of neuronal migration; most
remained in the SVZ, consistent with the results
obtained by transient expression (Fig. 5C) (Konno
et al. 2005). In contrast, when we expressed Rac1CA
under the control of the mouse GFAP or S100b pro-
moter, neurons expressing the co-electroporated
pCAX2-TagRFP were located normally in layer II–
IV at the stage when neuronal migration has almost
ﬁnished (P10) (Fig. 5D,E). Astrocytes expressing
Rac1CA were also observed throughout the cortex.
However, the number of labeled astrocytes was
reduced, compared with the control (Fig. 5D–G),
suggesting that the expression of Rac1CA may affect
early gliogenesis or survival. These results indicated
that using a glia-targeted promoter with Tol2 transpo-
son system facilitates investigation into the function of
genes involved in glial development and physiology
without affecting neuronal development.
Discussion
In utero electroporation was ﬁrst reported in 2001 and
has become widely used in the ﬁelds of developmen-
tal biology and neuroscience (Fukuchi-Shimogori &
Grove 2001; Saito & Nakatsuji 2001; Tabata & Nak-
ajima 2001). However, its application to date has
been limited to neurons. Use of high plasmid concen-
Figure 4 The mouse GFAP promoter and S100b promoter drove targeted expression of the transgene in glial cells. (A–G) Astro-
cyte-targeted expression of EGFP driven by the mouse GFAP promoter or S100b promoter. The E14.5 telencephalon was electro-
porated to introduce pT2K-GFAP-EGFP (A,B) or pT2K-S100b-EGFP (C,D) along with pCAX2-TagRFP and pCAGGS-T2TP
and analyzed at P10–12. TagRFP was expressed in pyramidal neurons (A,C). Higher magniﬁcation views of double-labeled cells
with EGFP by each promoter and cell type marker are shown in (A2–7) (GFAP) or (C2–4) (S100) (white arrows). The pial surface
is indicated by the white dotted line. (B,D) Percentages of GFAP- or S100-positive cells among EGFP-positive cells. (B:
124 cells⁄4 brains, D: 632 cells⁄5 brains) (E) Distribution of pT2K-GFAP-EGFP- or pT2K-S100b-EGFP-positive cells throughout
the cortex. Vertical lines indicate the ratio of EGFP-positive cells in each layer against total EGFP-positive cells in the brain. Each
line indicates an individual brain (GFAP; n = 4, S100b; n = 5). (F) Cells exhibiting typical morphology of oligodendrocytes. (G)
Dual differential labeling of astrocytes and neurons by pT2K-S100b-EGFP and pCAX2-TagRFP, respectively. Scale bars, 250 lm
(A,C, left), 50 lm (A, right six panels, F), 100 lm (C, right three panels) and 25 lm (G).
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507trations makes it possible to maintain and express
transgenes for several days in proliferative radial glia
and therefore is useful for studying neurogenesis.
With regard to gliogenesis, it was reported that
conventional in utero electroporation using higher
plasmid concentrations or carried out at a later stage
resulted in glial transgene expression (Tabata & Nak-
ajima 2001; LoTurco et al. 2009). However, these
strategies could not always lead to stable inheritance
in mitotic cells in a reproducible manner, and there-
fore, they were not suitable for glial study at postnatal
stages. In fact, there have been no reports of the use
of conventional in utero electroporation for postnatal
glial studies. Furthermore, peri⁄postnatal electropora-
tion or virus transfection may result in tissue damage
and inﬂammation (Buffo et al. 2008; Silver & Stein-
dler 2009). In contrast, combining in utero electropo-
ration with the Tol2-mediated gene transfer system
allows the introduction of transgenes when the
immune system is immature, and the plasticity of
developing tissues affords perturbation. This is a great
advantage for studying glia, which is sensitive to envi-
ronmental changes, both during postnatal develop-
ment and in physiological contexts. This ‘preloading
of transgenes’ in utero has been carried out by retrovi-
rus infection (Walsh & Cepko 1988; Noctor et al.
2001; Stott & Kirik 2006). The retroviral technique is
very useful for lineage tracing analysis by visualizing
individual cells during development, although it
requires the time-consuming process of packaging
retrovirus and strict control of the virus titer. In con-
trast, the Tol2 system is a convenient method for
integrating conventional and multiple plasmid expres-
sion vectors into the host cell genome to achieve sta-
ble expression. These features will facilitate
investigation into the role of various genes in glial
cells.
Previous studies showed that the neuron-speciﬁc
Ta1 promoter and radial glia-speciﬁc nestin promoter
(A)
(C)
(B)
(D) (E) (F)
(G)
Figure 5 Targeted expression of constitutively active Rac1
(Rac1CA) under the control of the mouse GFAP or S100b
promoter did not affect neuronal migration. (A,B) Expression
of pT2K-GFAP- or pT2K-S100b-EGFP detected by anti-GFP
immunostaining at E18.5. Some cells expressing EGFP were
positive for the radial glial marker, nestin (arrows). (C–G) Dis-
tributions of cells expressing pT2K-CAG-EGFP-Rac1CA (C),
pT2K-GFAP-EGFP-Rac1CA (D), pT2K-S100b-EGFP-Rac1CA
(E), pT2K-GFAP-EGFP (F) or pT2K-S100b-EGFP (G). Glial-
targeted expressions were visualized by anti-GFP immuno-
staining (D–G). Lateral neocortex electroporated at E14.5 was
examined at P16 (C) or P10 (D–G). Scale bars, 50 lm (A,B),
250 lm (C, left panel, D–G) and 100 lm (C, three rightmost
panels). The pial surface or the border between the ventricle
and SVZ is indicated by a white or cyan dotted line, respec-
tively.
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508are useful for labeling neuronal subtypes during devel-
opment by in utero electroporation (Tabata & Nakaj-
ima 2001; Gal et al. 2006; Wang et al. 2007).
Similarly, we showed here that astrocyte-targeted
expression can be achieved by in utero electroporation
using the mouse GFAP and S100b promoters com-
bined with the Tol2 system. Although expressions of
both the promoters were observed in radial glial cells
at E18.5, we could express EGFP-Rac1CA speciﬁ-
cally under the control of promoters in glia without
perturbing neuronal migration. Although further
studies are required to determine whether the mecha-
nism of migration is different between astrocytes and
neurons or overexpression of Rac1CA is cytotoxic
for gliogenesis and⁄or astrocytes, our results strongly
suggest that the Tol2-mediated gene transfer system is
very useful for investigating molecular⁄cellular func-
tion of genes of interest in glial development and
physiology without affecting neurons.
The number of EGFP-expressing astrocytes was
dependent on the efﬁciency of electroporation and
the amount of T2TP plasmid, as shown in Fig. 3A.
This suggests that it is possible to modulate labeling
efﬁciency to some extent by altering the volume or
concentration of plasmid injected into the ventricle.
However, inherent to this type of experimental
manipulation, it was difﬁcult to control the number
of labeled cells precisely. At best, more than 400 cells
per 150-lm slice of P10 brains could be successfully
and reproducibly induced to express EGFP driven by
the S100b promoter (data not shown). This level of
transgene expression should be more than sufﬁcient
for examining the behavior of single glial cells or for
detecting biological processes with a reporter gene in
vivo. In this respect, this system should be suitable for
studying glial–neuronal interactions in vivo, because
different transgenes can be expressed in a mutually
exclusive manner in neurons and glia, greatly facilitat-
ing such investigations (Fig. 4G). Likewise, it will
permit a variety of investigations regarding glial
development, glial–blood vessel interactions and glial
responses to environmental challenge. These usages
can be extended by adding RNAi experiments to the
repertoire, as the Tol2 system is compatible with
RNAi use, at least in chicken embryos (Watanabe
et al. 2007). Recent exhaustive studies using micro-
array or proteomics analyses have identiﬁed many
genes that are expressed in a cell-type-speciﬁc man-
ner. To screen candidate genes for important roles in
glial cells, using the Tol2-mediated gene transfer sys-
tem in vivo would allow the manipulation of gene
expression with less risk of infection or of triggering
immune responses. Therefore, this method may be
used with gene proﬁling methodologies, such as the
TRAP system by mRNA labeling of glial cells in vivo
(Doyle et al. 2008; Heiman et al. 2008).
In conclusion, this Tol2-mediated gene transfer sys-
tem combined with in utero electroporation is a power-
ful new option for glial study in addition to viral
transfection and transgenic strategies. It will allow the
analysis of numerous aspects of astrocytic development
and function and to dissect the contributions of the
responsible genes both conveniently and effectively.
Experimental procedures
Vector plasmids
The constructs pT2K-CAGGS-EGFP, pT2K-BI-EGFP,
pCAGGS-T2TP and pCAGGS-DsRed1 were previously
reported (Sato et al. 2007). To make pT2K-GFAP-EGFP,
pT2K-BI-EGFP was digested with EcoRI to remove the cassette
containing the TRE sequence. This site was blunted, and a
blunted DNA fragment containing the mouse GFAP promoter,
which was prepared from pGF1L (Miura et al. 1990) with
HindIII, was inserted. To make pT2K-S100b-EGFP, a 4.8-kb
mouse genomic DNA sequence containing the S100b promoter
region was ampliﬁed by PCR as described previously (Vives
et al. 2003). The PCR product was inserted into NdeI-EcoRI
site of pT2K-BI-EGFP. pT2K-GFAP-EGFP-Rac1CA and
pT2K-S100b-EGFP-Rac1CA were based on pT2K-GFAP-
EGFP, which was digested with NcoI, or pT2K-S100b-EGFP,
digested with EcoRI, blunt-ended, and digested with ClaI. The
vectors were ligated with a DNA fragment of pEGFP-Rac1V12
(Yasuda et al. 2004), ampliﬁed by PCR (primers: 5¢;CAT
GCCATGGTGAGCAAGGGCGAGG, 3¢;CCATCGATCCT
TACAACAGCAGGC), and digested with ClaI. To make
pT2K-CAG-EGFP-Rac1CA, pT2K-CAGGS-EGFP digested
with XbaI&EcoRV was ligated with the DNA fragment of
pEGFP-Rac1V12 treated with NheI&HpaI. pCAX2-TagRFP
was made from pCAX2, which contains the CAG promoter (an
upstream cytomegalovirus enhancer and chicken b-actin pro-
moter sequence). The pCAX2 was digested with EcoRI and
NotI and was ligated with a DNA fragment of pTagRFP-N
(#FP142; Evrogen), obtained by digestion with EcoRI and NotI.
Animals, electroporation and tissue processing
For the in utero electroporation, we used timed pregnant ICR
females at the indicated day of gestation. Mice were anesthetized
with sodium pentobarbitone at 70 lg per gram of body weight.
The surgery and manipulation were carried out as described
(Tabata & Nakajima 2001) with the modiﬁcations as following.
Plasmid concentration: 0.5 to 3 lg per lL, Electrode:
CUY650P3 or CUY650P5 (Nepa Gene) for E11.5, E12.5 or
E14.5, respectively, Electronic pulses: 33 V, four times, 30 or
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50950 ms at intervals of 970 or 950 ms at E11.5, E12.5 or E14.5,
respectively. The uterus was gently replaced, the incision was
closed, and normal development was allowed to continue. Mice
were killed at time points between E16.5 and P17 by cervical
dislocation or perfusion ﬁxation with 2–4% PFA, and the brain
was removed. Each brain was immersed in 4% PFA for 60–
120 min, embedded in 2% low melting point agar (NuSieve
 
3 : 1 Agarose; Lonza) and sliced into 150–180 lm coronal sec-
tions on a vibratome (VT1200S; Leica). To analyze the expres-
sion of transgene in radial glia at E16.5 or 18.5 or the
distribution of neurons at P8 and to evaluate BrdU incorpora-
tion, the ﬁxed brains were sunk in 25% sucrose and subse-
quently embedded in O.C.T. compound (Sakura) and frozen in
liquid nitrogen. Frozen coronal sections (20–30 lm) were cut
on a cryostat (CM3050S; Leica) (Table 1).
Immunohistochemistry
The primary antibodies were polyclonal rabbit anti-tRFP Ab
(AB232, 1 : 1000 dilution; Evrogen), mouse monoclonal anti-
GFP Abs (#11814 460001, 1 : 500 or 1 : 1000; Roche), rabbit
polyclonal anti-GFP Ab (#598, 1 : 1000; MBL), rabbit poly-
clonal anti-PH3 (06-570, 1 : 500; Upstate), mouse monoclonal
anti-nestin (Rat401; Developmental Studies Hybridoma Bank,
University of Iowa; 1 : 50), mouse monoclonal anti-GFAP
(G3893, 1 : 1000; Sigma), mouse monoclonal anti-NeuN
(MAB377, 1 : 1000; Chemicon), rabbit serum anti-Olig2
(a kind gift from H. Takebayashi; 1 : 1000), rabbit polyclonal
anti-S100 antibody (Z0311, 1 : 500; Dako), rat monoclonal
anti-BrdU Ab (ab6326, 1 : 500; Abcam) and rat monoclonal
anti-GFP Ab (#04404-26, 1 : 1000; Nacalai-tesque). Sections
cut on a Vibratome or cryostat were soaked in blocking buffer
(20% immunoblock; DS Pharma Biomedical Co., Ltd.) in PBST
(0.1% Triton-X in PBS) for 30–60 min and incubated with
primary antibodies in PBST overnight (or up to several days) at
4  C. After several washes in PBST, slices were incubated
with ﬂuorescence-labeled secondary antibodies (Jackson
Immunoresearch Lab) overnight at 4  C. All sections were co-
stained with TOTO-3 iodide (T3604, 1 : 3000; Invitrogen) or
HOECHST33342 (2 lM) to label nuclei. Pictures were
acquired with a TCS SP5 confocal microscope (Leica).
Quantitative analyses
The relative efﬁciency of electroporation in E16.5 animals
(Fig. 1G) was estimated by the relative intensity of DsRed1 in
the CP on cryostat sections. Fluorescence intensity was mea-
sured with LAS AF software (Leica) on the maximum projection
of intensity on images of a confocal z-stack. The effect of T2TP
on the retention of a transgene was determined by measuring
the intensity of EGFP in the SVZ⁄VZ on the same sections.
The CP and SVZ⁄VZ were deﬁned by morphological criteria.
In animals killed postnatally (Fig. 3A), the relative efﬁciency
of electroporation (I) was estimated by the intensity of EGFP
in the CP on vibratome brain slices. The ﬂuorescence intensity
of each slice was measured by Image J from its picture taken
on a camera-equipped ﬂuorescence stereoscopic microscope
(Leica). For each brain, the numbers of labeled glial cells were
counted in one slice; the slice that had the highest EGFP
intensity in CP was used. The slices were observed on a con-
focal microscope, and cells with a bushy morphology (clearly
distinct from that of neurons) were counted as glial cells.
Because the thickness of the sections and area scanned by con-
focal microscopy to count glial cells differed among the sam-
ples, we normalized the glial cell number (G) by dividing it by
the volume (V) [slice thickness (lm) · the area]. To represent
the relationship between (G) and (I), (G) was plotted against
(I · V), which is equal to (G⁄V) against (I).
For analyzing expression pattern of EGFP driven by GFAP
or S100b promoter, EGFP-positive cells were taken pictures
with confocal microscopy on all sections and their numbers
were counted. These numbers were classiﬁed by their location
Table 1 Concentration of plasmids introduced by in utero electroporation (lg⁄lL)
CAG-EGFP
at E11.5
CAG-EGFP
at E12.5
CAG-EGFP
at E14.5
Birth-date
labeling
GFAP⁄
S100b-
EGFP
CAG-
EGFP-
Rac1CA
GFAP⁄S100b-
EGFP-
Rac1CA
pT2K-CAGGS-EGFP 0.6 0.6 3.0 3.0
pT2K-GFAP⁄S100b-EGFP 1.5
pT2K-CAG-EGFP-Rac1CA 2.0
pT2K-GFAP⁄
S100b-EGFP-Rac1CA
1.5
pCAGGS-T2TP 1.5 1.5 0–2.0 1.0 1.0 1.0 1.0
pCAX2-TagRFP 0 or 1.5 0.5–1.0 1.0 0.5–0.75
pCAGGS-DsRed 1.5 1.5
Electroporation ﬁ Fixation E11.5
ﬁ E16.5
E12.5 ﬁ
E16.5 or P8
E14.5 ﬁ
P16–17
E14.5 ﬁ
P5 (BrdU
injection
at P4)
E14.5 ﬁ
E18.5 or
P10–P12
E14.5 ﬁ
P16
E14.5 ﬁ P10
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510into cerebral cortex, SVZ, WM, and from layer VI to I. The
expression patterns in whole brain were obtained as a total of
sections per individual and plotted in the graph.
BrdU labeling
Newborn mice subjected to in utero electroporation at E14.5
were given an injection of BrdU of 100 lg⁄g body weight at
P4 and killed 28 hours later. Frozen sections were prepared
from each brain as described earlier and incubated with rabbit
polyclonal anti-GFP Ab (1 : 1000) for 3 hours at room tem-
perature (rt) and then with secondary antibodies for 1 hour at
rt. The sections were ﬁxed again with 4% PFA for 20 min at
rt, washed in PBS twice, incubated with 2 N HCl for 15 min
at 37  C, washed in PBS twice, incubated with blocking buf-
fer for 30 min at 4  C and then incubated with rat monoclo-
nal anti-BrdU Ab overnight at 4  C. After three washes in
PBST, they were incubated with secondary antibody for
1 hour at rt and mounted.
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